TELO compared with CTM: revenue, margins and what each company keeps, and the suppliers and customers both name

TELOTelomir Pharmaceuticals, Inc.

Mkt capRevenueRevenue

CTMCastellum, Inc.

Mkt capRevenueRevenue

Compare

TELOTelomir Pharmaceuticals, Inc.

CTMCastellum, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TELO

No earnings history for TELO.

CTM2 of 4 reports

Reportimpliedrealized× implied

Q3 FY26—▼−19.93%—

Q2 FY26—▼−0.81%—

= impliedTELO realized, solidCTM realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

TELOTelomir Pharmaceuticals, Inc.

0.73▼−6.72%· post 0.73

Mkt cap$52.3MRevenue—Revenue—

CTMCastellum, Inc.

0.37▼−22.06%· post 0.39

ClosedNov 6 '26

Mkt cap$36.0MRevenue$15MQ3 FY26Revenue$53MFY25

Compare

ClosedNov 6 '26

TELOTelomir Pharmaceuticals, Inc.

CTMCastellum, Inc.

0.73▼−6.72%post 0.73

Price

0.37▼−22.06%post 0.39

$52.3M

Mkt cap

$36.0M

—

Revenue

$15MQ3 FY26

—

Revenue

$53MFY25

TELO0.73▼−6.72%vsCTM0.37▼−22.06%ClosedNov 6 '26